StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
VSTM

Verastem, Inc.

VSTM Nasdaq Pharmaceutical Preparations EDGAR ↗
$5.69
-0.41 -6.72%

Key statistics

from XBRL data in SEC filings
Market cap
$500M
Revenue (TTM)
$30.9M
Net income (TTM)
-$194M
EPS (TTM)
$-2.52
P/E ratio
Dividend yield
Free cash flow
-$138M
Cash
$166M
Total assets
$228M
Gross margin
52-week range
$3.43 – $11.25

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure; Other events Jun 23, 2026 8-K Regulation FD disclosure; Other events Jun 17, 2026 8-K Shareholder vote results May 26, 2026 8-K Regulation FD disclosure May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Regulation FD disclosure Mar 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 4, 2026 8-K Regulation FD disclosure Jan 8, 2026 8-K Regulation FD disclosure; Other events Dec 31, 2025 8-K Director or officer change; Regulation FD disclosure Dec 19, 2025 8-K Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 8-K Regulation FD disclosure; Other events Oct 23, 2025 8-K Regulation FD disclosure; Other events Oct 20, 2025 8-K Regulation FD disclosure Sep 8, 2025 8-K Regulation FD disclosure; Other events Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Regulation FD disclosure Jun 2, 2025 8-K Regulation FD disclosure; Other events Jun 2, 2025 8-K Shareholder vote results; Regulation FD disclosure; Other events May 23, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Regulation FD disclosure; Other events May 8, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 25, 2025 8-K Regulation FD disclosure Mar 20, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Regulation FD disclosure; Other events Jan 23, 2025 8-K Director or officer change Jan 21, 2025 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Other events Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Regulation FD disclosure; Other events Oct 17, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Other events Jul 25, 2024 8-K Other events Jul 23, 2024 8-K Regulation FD disclosure Jun 26, 2024 8-K Regulation FD disclosure; Other events May 24, 2024 8-K Shareholder vote results; Regulation FD disclosure; Other events May 23, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Regulation FD disclosure Apr 9, 2024